State Street SPDR S&P Biotech ETF (XBI)
NYSEARCA: XBI · Real-Time Price · USD
132.74
+3.89 (3.02%)
At close: Jun 11, 2026, 4:00 PM EDT
132.76
+0.02 (0.02%)
After-hours: Jun 11, 2026, 8:00 PM EDT
XBI Holdings Information
XBI is an equity ETF with a total of 153 individual holdings. The top holdings are Travere Therapeutics stock at 1.92%, Alkermes at 1.87%, TG Therapeutics at 1.81%, Revolution Medicines at 1.76%, and Twist Bioscience at 1.75%.
Total Holdings
153
Top 10 Percentage
16.42%
Asset Class
Equity
ETF Category
Health
Assets
7.87B
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | TVTX | Travere Therapeutics, Inc. | 1.92% |
| 2 | ALKS | Alkermes plc | 1.87% |
| 3 | TGTX | TG Therapeutics, Inc. | 1.81% |
| 4 | RVMD | Revolution Medicines, Inc. | 1.76% |
| 5 | TWST | Twist Bioscience Corporation | 1.75% |
| 6 | NBIX | Neurocrine Biosciences, Inc. | 1.49% |
| 7 | EXEL | Exelixis, Inc. | 1.48% |
| 8 | ARWR | Arrowhead Pharmaceuticals, Inc. | 1.48% |
| 9 | NUVL | Nuvalent, Inc. | 1.44% |
| 10 | KRYS | Krystal Biotech, Inc. | 1.42% |
| 11 | BEAM | Beam Therapeutics Inc. | 1.37% |
| 12 | APGE | Apogee Therapeutics, Inc. | 1.33% |
| 13 | VCYT | Veracyte, Inc. | 1.33% |
| 14 | NTRA | Natera, Inc. | 1.33% |
| 15 | PTCT | PTC Therapeutics, Inc. | 1.31% |
| 16 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.29% |
| 17 | PTGX | Protagonist Therapeutics, Inc. | 1.28% |
| 18 | INCY | Incyte Corporation | 1.28% |
| 19 | CYTK | Cytokinetics, Incorporated | 1.26% |
| 20 | HALO | Halozyme Therapeutics, Inc. | 1.26% |
| 21 | SRRK | Scholar Rock Holding Corporation | 1.23% |
| 22 | BIIB | Biogen Inc. | 1.22% |
| 23 | MIRM | Mirum Pharmaceuticals, Inc. | 1.22% |
| 24 | CRSP | CRISPR Therapeutics AG | 1.21% |
| 25 | UTHR | United Therapeutics Corporation | 1.19% |
As of Jun 9, 2026